Works matching IS 17562856 AND DT 2018 AND VI 11
Results: 79
Long-term evaluation of NEDA-3 status in relapsing-remitting multiple sclerosis patients after switching from natalizumab to fingolimod.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2018, v. 11, p. 1, doi. 10.1177/1756286418791103
- By:
- Publication type:
- Article
Role of immune responses for extracellular matrix remodeling in the ischemic brain.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2018, v. 11, p. 1, doi. 10.1177/1756286418818092
- By:
- Publication type:
- Article
Corrigendum.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2018, v. 11, p. 1, doi. 10.1177/1756286418765591
- Publication type:
- Article
B cell-based therapies in CNS autoimmunity: differentiating CD19 and CD20 as therapeutic targets.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2018, v. 11, p. 1, doi. 10.1177/1756286418761697
- By:
- Publication type:
- Article
Differential immunological profiles herald magnetic resonance imaging-defined perioperative cerebral infarction.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2018, v. 11, p. 1, doi. 10.1177/1756286418759493
- By:
- Publication type:
- Article
Effect of the combination of motor imagery and electrical stimulation on upper extremity motor function in patients with chronic stroke: preliminary results.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2018, v. 11, p. 1, doi. 10.1177/1756286418804785
- By:
- Publication type:
- Article
Nusinersen for spinal muscular atrophy.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2018, v. 11, p. 1, doi. 10.1177/1756285618754459
- By:
- Publication type:
- Article
A decade of Therapeutic Advances in Neurological Disorders.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2018, v. 11, p. 1, doi. 10.1177/1756286418813258
- By:
- Publication type:
- Article
One-year follow up of three Italian patients with Duchenne muscular dystrophy treated with ataluren: is earlier better?
- Published in:
- Therapeutic Advances in Neurological Disorders, 2018, v. 11, p. 1, doi. 10.1177/1756286418809588
- By:
- Publication type:
- Article
Treatment of an acute motor and sensory axonal neuropathy with propionate in a 33-year-old male.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2018, v. 11, p. 1, doi. 10.1177/1756286418809580
- By:
- Publication type:
- Article
Evaluation of pregnancy outcomes in patients with multiple sclerosis after fingolimod exposure.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2018, v. 11, p. 1, doi. 10.1177/1756286418804760
- By:
- Publication type:
- Article
Successful therapy with rituximab in three patients with probable neurosarcoidosis.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2018, v. 11, p. 1, doi. 10.1177/1756286418805732
- By:
- Publication type:
- Article
Prolonged-release fampridine in multiple sclerosis: clinical data and real-world experience. Report of an expert meeting.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2018, v. 11, p. 1, doi. 10.1177/1756286418803248
- By:
- Publication type:
- Article
Feasibility and safety of intrathecal treatment with nusinersen in adult patients with spinal muscular atrophy.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2018, v. 11, p. 1, doi. 10.1177/1756286418803246
- By:
- Publication type:
- Article
Primary central nervous system lymphoma.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2018, v. 11, p. 1, doi. 10.1177/1756286418793562
- By:
- Publication type:
- Article
Choices for long-term hypertensive control in patients after first-ever hemorrhagic stroke: a nationwide cohort study.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2018, v. 11, p. 1, doi. 10.1177/1756286418802688
- By:
- Publication type:
- Article
Role of polymorphonuclear neutrophils in the reperfused ischemic brain: insights from cell-type-specific immunodepletion and fluorescence microscopy studies.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2018, v. 11, p. 1, doi. 10.1177/1756286418798607
- By:
- Publication type:
- Article
Short-term disability progression in two multiethnic multiple sclerosis centers in the treatment era.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2018, v. 11, p. 1, doi. 10.1177/1756286418793613
- By:
- Publication type:
- Article
Comparable efficacy and safety of dimethyl fumarate and teriflunomide treatment in Relapsing-Remitting Multiple Sclerosis: an Italian real-word multicenter experience.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2018, v. 11, p. 1, doi. 10.1177/1756286418796404
- By:
- Publication type:
- Article
Peginterferon β-1a every 2 weeks increased achievement of no evidence of disease activity over 4 years in the ADVANCE and ATTAIN studies in patients with relapsing–remitting multiple sclerosis.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2018, v. 11, p. 1, doi. 10.1177/1756286418795085
- By:
- Publication type:
- Article
Long-term outcomes of peginterferon beta-1a in multiple sclerosis: results from the ADVANCE extension study, ATTAIN.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2018, v. 11, p. 1, doi. 10.1177/1756286418791143
- By:
- Publication type:
- Article
Application of immunotherapy for neurological manifestations in hypermobile Ehlers–Danlos syndrome.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2018, v. 11, p. 1, doi. 10.1177/1756286418793766
- By:
- Publication type:
- Article
Can inflammation be resolved in Alzheimer’s disease?
- Published in:
- Therapeutic Advances in Neurological Disorders, 2018, v. 11, p. 1, doi. 10.1177/1756286418791107
- By:
- Publication type:
- Article
Inflammatory molecules might become both biomarkers and therapeutic targets for stroke management.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2018, v. 11, p. 1, doi. 10.1177/1756286418789340
- By:
- Publication type:
- Article
Anti-inflammatory treatments for stroke: from bench to bedside.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2018, v. 11, p. 1, doi. 10.1177/1756286418789854
- By:
- Publication type:
- Article
Immunological and non-immunological effects of stem cell-derived extracellular vesicles on the ischaemic brain.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2018, v. 11, p. 1, doi. 10.1177/1756286418789326
- By:
- Publication type:
- Article
Prospects of siponimod in secondary progressive multiple sclerosis.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2018, v. 11, p. 1, doi. 10.1177/1756286418788013
- By:
- Publication type:
- Article
Clinical trials in multiple sclerosis: milestones.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2018, v. 11, p. 1, doi. 10.1177/1756286418785499
- By:
- Publication type:
- Article
Primary angiitis of the central nervous system: diagnosis and treatment.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2018, v. 11, p. 1, doi. 10.1177/1756286418785071
- By:
- Publication type:
- Article
Antisense oligonucleotides in neurological disorders.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2018, v. 11, p. 1, doi. 10.1177/1756286418776932
- By:
- Publication type:
- Article
Combined walking outcome measures identify clinically meaningful response to prolonged-release fampridine.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2018, v. 11, p. 1, doi. 10.1177/1756286418780007
- By:
- Publication type:
- Article
MRI features as a helpful tool to predict the molecular subgroups of medulloblastoma: state of the art.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2018, v. 11, p. 1, doi. 10.1177/1756286418775375
- By:
- Publication type:
- Article
Inflammation in stroke: the role of cholinergic, purinergic and glutamatergic signaling.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2018, v. 11, p. 1, doi. 10.1177/1756286418774267
- By:
- Publication type:
- Article
Ischemia–reperfusion injury in stroke: impact of the brain barriers and brain immune privilege on neutrophil function.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2018, v. 11, p. 1, doi. 10.1177/1756286418794184
- By:
- Publication type:
- Article
Intravenous thrombolysis for acute ischemic stroke in Greece: the Safe Implementation of Thrombolysis in Stroke registry 15-year experience.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2018, v. 11, p. 1, doi. 10.1177/1756286418783578
- By:
- Publication type:
- Article
Danger signals in stroke and their role on microglia activation after ischemia.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2018, v. 11, p. 1, doi. 10.1177/1756286418774254
- By:
- Publication type:
- Article
Phase IV study of retention on fingolimod versus injectable multiple sclerosis therapies: a randomized clinical trial.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2018, v. 11, p. 1, doi. 10.1177/1756286418774338
- By:
- Publication type:
- Article
Tryptophan immunoadsorption during pregnancy and breastfeeding in patients with acute relapse of multiple sclerosis and neuromyelitis optica.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2018, v. 11, p. 1, doi. 10.1177/1756286418774973
- By:
- Publication type:
- Article
The role of dopaminergic immune cell signalling in poststroke inflammation.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2018, v. 11, p. 1, doi. 10.1177/1756286418774225
- By:
- Publication type:
- Article
Ocrelizumab: a new milestone in multiple sclerosis therapy.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2018, v. 11, p. 1, doi. 10.1177/1756286418773025
- By:
- Publication type:
- Article
Epigenetic regulation of inflammation in stroke.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2018, v. 11, p. 1, doi. 10.1177/1756286418771815
- By:
- Publication type:
- Article
Immunotherapy of experimental and human stroke with agents approved for multiple sclerosis: a systematic review.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2018, v. 11, p. 1, doi. 10.1177/1756286418770626
- By:
- Publication type:
- Article
Beta adrenoceptor blockade ameliorates impaired glucose tolerance and alterations of the cerebral ceramide metabolism in an experimental model of ischemic stroke.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2018, v. 11, p. 1, doi. 10.1177/1756286418769830
- By:
- Publication type:
- Article
Postherpes simplex encephalitis: a case series of viral-triggered autoimmunity, synaptic autoantibodies and response to therapy.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2018, v. 11, p. 1, doi. 10.1177/1756286418768778
- By:
- Publication type:
- Article
Commentary on the ECTRIMS–EAN guideline for pharmacological treatment of multiple sclerosis.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2018, v. 11, p. 1, doi. 10.1177/1756286418770378
- By:
- Publication type:
- Article
Incidence and mitigation of gastrointestinal events in patients with relapsing–remitting multiple sclerosis receiving delayed-release dimethyl fumarate: a German phase IV study (TOLERATE).
- Published in:
- Therapeutic Advances in Neurological Disorders, 2018, v. 11, p. 1, doi. 10.1177/1756286418768775
- By:
- Publication type:
- Article
Defining distinct features of anti-MOG antibody associated central nervous system demyelination.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2018, v. 11, p. 1, doi. 10.1177/1756286418762083
- By:
- Publication type:
- Article
New developments in brain metastases.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2018, v. 11, p. 1, doi. 10.1177/1756286418785502
- By:
- Publication type:
- Article
The meningeal and choroidal infiltration routes for leukocytes in stroke.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2018, v. 11, p. 1, doi. 10.1177/1756286418783708
- By:
- Publication type:
- Article
Neurological complications of immune checkpoint inhibitors: what happens when you ‘take the brakes off’ the immune system.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2018, v. 11, p. 1, doi. 10.1177/1756286418799864
- By:
- Publication type:
- Article